







Bifunctional Iminophosphorane Catalyzed Enantioselective Sulfa-Michael Addition of Alkyl 
Thiols to Alkenyl Benzimidazoles  
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Abstract: The first enantioselective sulfa-Michael addition of alkyl thiols to alkenyl benzimidazoles, 
enabled by a bifunctional iminophosphorane (BIMP) organocatalyst, is described. The iminophosphorane 
moiety of the catalyst provides the required basicity to deprotonate the thiol nucleophile while the chiral 
scaffold and H-bond donor control facial selectivity. The reaction is broad in scope with respect to the 
thiol and benzimidazole reaction partners with the reaction proceeding in up to 98% yield and 96:4 er. 
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1/ General Information 
Reactions were carried out under a nitrogen atmosphere in oven-dried glassware at room temperature 
(22 °C) unless stated otherwise. Standard inert atmosphere techniques were used in handling all air and 
moisture sensitive reagents. Thin-layer chromatography (TLC) was performed using Merck aluminium 
backed sheets coated with Merck Kieselgel 60 F254 (230-400 mesh) fluorescent treated silica, which 
were visualised under UV light (λmax= 254 or 365 nm). Flash column chromatography was performed 
using Merck Kieselgel (230-400 mesh). All 1H,13C and 19F NMR spectra were recorded using a Bruker 
500 MHz and Bruker 400 MHz spectrometers and are quoted in ppm for measurement against a 
tetramethylsilane (TMS) or residual solvent peak internal standard. Coupling constants (J) are reported in 
hertz (Hz). Two-dimensional spectroscopy (COSY, HSQC and HMBC) was used to assist in the 
assignment and the data is not reported. IR spectra were recorded on a Bruker Tensor 27 FT-IR 
spectrometer deposited as a thin film. Melting points were recorded using a Leica Galen III hot-stage 
microscope apparatus and are reported uncorrected in degrees Celsius (°C). Low resolution mass spectra 
were recorded on a Waters LCT premier XE Micromass spectrometer (ESI). High resolution mass spectra 
(ESI) were recorded on a Bruker MicroTof mass spectrometer. Optical rotations were recorded using a 
Perkin Elmer 341 polarimeter; [α]D T values are reported in 10
-1 deg·cm2 g-1 ; concentrations (c) are 
quoted in g/100 mL; D refers to the D-line of sodium (589 nm); temperatures (T) are given in degrees 
Celsius (°C). (+) and (–) compound number prefixes indicate the sign of the optical rotation. The 
enantiomeric excesses were determined by HPLC analysis on an Agilent 1200 Series instrument 
employing a chiral stationary phase column specified in the individual experiment and by comparing the 
samples with the appropriate racemic mixtures. Concentration under reduced pressure was performed by 
rotary evaporation at the appropriate pressure and temperature. Reagents used were obtained from 
commercial suppliers or purified according to standard procedures. Petroleum ether refers to distilled 
light petroleum of fraction 30 - 40 °C. Anhydrous toluene, tetrahydrofuran, dichloromethane and diethyl 
ether were dried by filtration through activated alumina (powder ~150 mesh, pore size 58 Å, basic, Sigma-
Aldrich) columns. Dimethyl sulfoxide and dimethylformamide were used as supplied. Deuterated 





2/ Reaction Optimization 




Entry Catalyst [c] Mol/L-1 Yield % e.r 
1 A 0.50 12 53:47 
2 B 0.50 80 83/17 
3 C 0.25 92 86/14 
4 D 0.50 83 66/34 
5 E 0.50 95 83/17 
6 F 0.50 90 90/10 


















Temp. (°C) Yield % e.r  
1 Ts THF 3.0 0.50 22  90 90/10 
2 Ts THF 3.0 0.25 22 86 91/9 
3 Ts THF 3.0 0.125 22 86 90/10 
4 Ts THF 3.0 0.50 12 83 90/10 
5 Ts THF 3.0 0.50 -15 93 92/8 
6 Ts THF 3.0 0.50 -40 88 82/18 
7 Ts TBME 3.0 0.50 22 80 91/9 
8 Ts 2-MeTHF 3.0 0.50 22 80 91/9 
9 Ts 1,4-dioxane 3.0 0.50 22 79 89/11 
10 Ts CH2Cl2 3.0 0.50 22 70 91/9 
11 Ts MeCN 3.0 0.50 22 81 73/27 
12 Ts Toluene 3.0 0.50 22 92 89/11 
13 Ts 2-MeTHF 3.0 0.06 22 55 91/9 
14 Ts Et
2
O 3.0 0.06 22 92 93/7 
15 Ts Et
2
O 2.0 0.25 22 92 91/9 
16 Ts Et
2
O 1.2 0.25 22 94 92/8 
17 Ts 2-MeTHF 3.0 0.50 0 85 91/9 
18 Ts TBME 3.0 0.50 0 92 92/8 
19 Ts THF 0.5 
then 
0.7 
0.50 22 86 90/10 
20 Ts Et
2
O 1.2 0.06 0 93 94/6 
21 Boc THF 3.0 0.50 22 84 91/9 





O 1.2 0.06 22 
 
98 95/5 





3/ Control Experiments 




Entry Catalyst Yield er 
1 None 24 % N/A 
2 A 12 % 53/47 
3 H 6 %  52/48 
4 None (Basified Thiol)a 12% N/A 
5 Et3N (Basified Thiol)a trace N/A 
6 Benzoic Acid (Basified Thiol)a 89% N/A 
7 A (Basified Thiol)a 12 %   52/48 
8 I (Basified Thiol)a 33 %  N/A 
9b G (Basified Thiol)a 87%  94.5/5.5 
aThiol was basified by allowing it to stand over K2CO3 for 24 h. b Reaction performed in 










4/ Synthesis of precatalysts and catalysts  
 
Catalysts A,1 B,2 C and F-G,3 D-E,4 H,5 I6 were prepared according to literature procedures. 
5/ Preparations of N-Ts protected alkenyl benzimidazole 
 
Non commercially available aldehydes were prepared by simple oxidation of the corresponding alcohol 
with Dess-Martin Periodinane following the procedure reported by Snowden et al.7   
tert-butyl-2-((diethoxyphosphoryl)methyl)-1H-benzo[d]imidazole-1-carboxylate (Bz0), N-Ts 
benzimidazoles 1, Bz1, Bz2, N-Boc- and N-Cbz benzimidazoles Bz3 and Bz4 were prepared as described 









To a mixture of crotonic acid (2.68 g, 30 mmol) in polyphosphoric acid (12 g) was added 4-bromo-1,2-
diaminobenzene (5.61 g, 30 mmol). The reaction was heated at 180 °C for 12 h. The mixture was cooled 
down to 22 °C and poured carefully onto a saturated solution of NaHCO3. Solid NaHCO3 was added until 
neutral pH was obtained. The solution was diluted with EtOAc and water then stirred vigorously for 10 
min. The aqueous phase was extracted twice with EtOAc and the combined organic phase were washed 
with brine, dried over MgSO4 and concentrated under vacuum affording 3.9 g of purple solid. 
The crude residue (2.0 g, 8.4 mmol) was dissolved in acetone (40 mL), NEt3 (1.41 mL, 10.1 mmol) was 
added then TsCl (1.77 g, 9.3 mmol). The mixture was stirred for 24h at 22 °C. The solvent was removed 
                                                 
 
1  B. Vakulya, S. Varga, A. Csámpai and T. Soós, Org. Lett., 2005, 7, 1967. 
2 M. G. Núñez, A. J. M. Farley and D. J. Dixon, J. Am. Chem. Soc., 2013, 135, 16348. 
3 J. Yang, A. J. M. Farley and D. J. Dixon, Chem. Sci., 2017, 8, 606. 
4 G. P. Robertson, A. J. M. Farley and D. J. Dixon, Synlett, 2016, 27, 21. 
5  J. Ye, D. J. Dixon and P. S. Hynesa Chem. Commun., 2005, 0, 4481. 
6 Y. Okino, Y. Hoashi, T. Furukawa and X.  Xu, Y. Takemoto, J. Am. Chem. Soc., 2005, 127, 119. 
7 M. K. Gupta, Z. Li and T. S. Snowden J. Org. Chem., 2012, 77, 4854. 
8 Y-Y. Wang, K. Kanomata, T. Korenaga and M. Terada Angew.Chem. Int. Ed., 2016, 55, 927. 
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under vacuum and the crude was purified by flash chromatography on silica gel (pentane 9/ EtOAc 1). A 
subsequent trituration of each compound in a mixture of pentane/ Et2O (1/1) afford pure (E)-6-bromo-2-
(prop-1-en-1-yl)-1-tosyl-1H-benzo[d]imidazole (Bz5) as a white solid (m = 0.38 g, 12 %) and (E)-5-







Mp : 160°C (from EtOAc/Petrol); 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 1.8 Hz, 1H), 7.78 (d, J = 
8.5 Hz, 2H), 7.50 (d, J = 8.5 Hz, 1H), 7.44 (dd, J = 8.5, 1.8 Hz, 1H), 7.30 (d, J = 7.8 Hz, 2H), 7.20 – 7.14 
(m, 1H), 7.10 (dq, J = 15.3, 6.2 Hz, 1H), 2.40 (s, 3H), 2.05 (d, J = 5.2 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ 151.6, 146.3, 141.6 140.4, 135.2, 133.9, 130.4, 128.5, 127.0, 120.9, 118.2, 118.1, 117.0, 77.5, 
77.2, 76.8, 21.8, 19.3; IR (film) υmax/cm
-1: 1642, 1597, 1423, 1378, 1166, 1039, 812, 710, 666; HRMS 
(ESI+): calcd. for C17H16O₂N₂BrS [M+H]






Mp : 128°C (from EtOAc/Petrol); 1H NMR (400 MHz, CDCl3) δ 7.90 (d, J = 8.8 Hz, 1H), 7.77 – 7.70 
(m, 3H), 7.41 (dd, J = 8.8, 1.9 Hz, 1H), 7.29 – 7.22 (m, 2H), 7.21 – 7.12 (m, 1H), 7.09 (dq, J = 15.3, 5.3 
Hz, 2H), 2.37 (s, 3H), 2.04 (d, J = 5.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 152.2, 146.7, 143.9, 140.8, 
135.7, 132.0, 130.3, 127.8, 126.9, 122.7, 118.2, 118.2, 115.7, 77.5, 77.7, 76.8, 21.8, 19.3; IR (film) 
υmax/cm
-1: 1644, 1596, 1446, 1379, 1166, 1048, 809, 732, 665; HRMS (ESI+): calcd. for C17H16O₂N₂BrS 












General procedure I for the synthesis of N-Ts precursors (GP I): 
 
To a solution of N-Boc protected benzimidazole Bz0 (368 mg, 1.0 mmol) in dry THF (12 mL) at 0°C was 
added portionwise NaH 60% (w/w in oil) (64 mg, 1.6 mmol) and stirred under N2 at 0 °C for 30 min. The 
corresponding aldehyde (2.0 mmol) was added at 0 °C then the reaction was allowed to warm to 22 °C 
and stirred for 12 h. The mixture was quenched by adding water and the aqueous phase was extracted 
with EtOAc. The combined organic phase were washed with brine, dried over MgSO4 and concentrated 
under reduced pressure. 
The residue was taken in dry CH2Cl2 (1 mL/ 1mmol) and cooled to 0°C. TFA (1mL/ 1 mmol) was added 
and the reaction was stirred at 22 °C until TLC shows complete disappearance of the starting material. 
The mixture was quenched by adding a saturated solution of NaHCO3. The aqueous layer was extracted 
with EtOAc. The combined organic phase were washed with brine, dried over MgSO4 and concentrated 
under reduced pressure. 
The crude was dissolved in CH2Cl2, acetone or DMF (5 mL/1 mmol), then NEt3 (2.0 eq) and TsCl (1.2 
eq) was added. The mixture was stirred over 48h at 22 °C then volatiles were removed under vacuum. 







(E)-2-(Hex-1-en1-yl)-1-tosyl-1H-benzo[d]imidazole was synthesized following GP I using hexanal 
(200.3 mg, 2.0 mmol, 246 µL) as the aldehyde. Acetone was used as a solvent for the N-tosylation. 
Purification by flash chromatography on silica gel (8 pentane/2 Et2O) afforded pure Bz7 as a colourless 
oil. (156 mg, 0.440 mmol, 50% overall yield).  
 
1H NMR (400 MHz, CDCl3) δ = 8.10 – 8.01 (m, 1H), 7.76 (d, J = 8.0 Hz, 2H), 7.67 – 7.59 (m, 1H), 7.36 
– 7.28 (m, 2H), 7.24 (d, J = 8.0 Hz, 3H), 7.18 (dt, J = 15.5, 1.3 Hz, 1H), 7.07 (dt, J = 15.5, 6.9 Hz, 1H), 
2.40 – 2.32 (m, 5H), 1.58 – 1.48 (m, 2H), 1.47 – 1.34 (m, 2H), 0.95 (t, J = 7.3 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ = 151.3, 145.9, 144.8, 142.6, 135.6, 133.1, 130.2, 127.0, 125.1, 124.9, 119.9, 117.3, 
114.0, 33.2, 30.8, 22.4, 21.8, 14.1; IR (film) υmax/cm
-1: 2957, 2928, 1640, 1448, 1377, 1169, 1120, 1089, 
743, 670; HRMS (ESI+): calcd. for C20H23O₂N₂S [M+H]








(E)-2-(4-Phenylbut-1-en-1-yl)-1-tosyl-1H-benzo[d]imidazole was synthesized following GP I using 3-
phenylpropanal (268.3 mg, 2.0 mmol, 263 µL) as the aldehyde. DMF was used as a solvent for the 
tosylation. Purification by flash chromatography on silica gel (9 pentane/1 EtOAc) afforded pure Bz8 as 
a yellow solid. (130 mg, 0.322 mmol, 30% overall yield). 
 
Mp : 90°C (from EtOAc/Petrol); 1H NMR (400 MHz, CDCl3) δ = 8.10 – 7.98 (m, 1H), 7.68 (d, J = 8.5 
Hz, 2H), 7.65 – 7.62 (m, 1H), 7.36 – 7.30 (m, 3H), 7.28 – 7.24 (m, 3H), 7.23 – 7.19 (m, 3H), 7.14 (dt, J 
= 15.5, 6.5 Hz, 1H), 2.89 (dd, J = 8.8, 6.5 Hz, 2H), 2.75 – 2.68 (m, 2H), 2.36 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 151.0, 145.9, 143.3, 142.6, 141.1, 135.4, 133.0, 130.2, 128.6, 128.6, 126.9, 126.2, 125.16, 
125.0, 119.9, 117.9, 114.0, 77.5, 77.2, 76.8, 34.9, 34.9, 21.8; IR (film) υmax/cm
-1: 3026, 2923, 1641, 1597, 
1449, 1377, 1173, 1049, 743, 670; HRMS (ESI+): calcd. for C24H23O₂N₂S [M+H]







(E)-2-(Hepta-1,6-dien-1-yl)-1-tosyl-1H-benzo[d]imidazole was synthesized following GP I hex-5-enal 
(196.3 mg, 2.0 mmol) as the aldehyde. CH2Cl2 was used as a solvent for the N-tosylation. Purification by 
flash chromatography on silica gel (9 pentane/1 EtOAc) afforded pure Bz9 as a colourless oil. (310 mg, 
0.846 mmol, 44% overall yield). 
 
1H NMR (400 MHz, CDCl3) δ 8.08 – 8.03 (m, 1H), 7.76 (d, J = 8.4 Hz, 2H), 7.70 – 7.58 (m, 1H), 7.39 – 
7.29 (m, 2H), 7.25 (d, J = 0.8 Hz, 2H), 7.20 (dt, J = 15.4, 1.4 Hz, 1H), 7.07 (dt, J = 15.5, 6.9 Hz, 1H), 
5.84 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.12 – 4.97 (m, 2H), 2.45 – 2.38 (m, 1H), 2.36 (s, 3H), 2.22 – 2.05 
(m, 2H), 1.65 (p, J = 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 151.2, 146.0, 144.3, 142.6, 138.3, 
135.5, 133.1, 130.2, 126.9, 125.2, 124.9, 119.9, 117.6, 115.2, 114.0, 33.4, 32.8, 27.9, 21.8; IR (film) 
υmax/cm
-1: 3076, 2927, 1640, 1448, 1378, 1171, 1049, 919, 744, 670; HRMS (ESI+): calcd. for 
C21H23O₂N₂S [M+H]








(E)-2-(Hex-1-en-5-yn-1-yl)-1-tosyl-1H-benzo[d]imidazole was synthesized following GP I using pent-
4-ynal (164.2 mg, 2.0 mmol) as the aldehyde. CH2Cl2 was used as a solvent for the tosylation. Purification 
by flash chromatography on silica gel (8 pentane/2 EtOAc) afforded pure Bz10 as a white solid. (170 mg, 
0.485 mmol, 26% overall yield). 
 
Mp : 104°C (from EtOAc/Petrol); 1H NMR (400 MHz, CDCl3) δ = 8.07 – 8.01 (m, 1H), 7.78 (d, J = 8.5 
Hz, 2H), 7.67 – 7.60 (m, 1H), 7.35 – 7.27 (m, 3H), 7.23 (d, J = 8.5 Hz, 2H), 7.09 (dt, J = 15.5, 6.7 Hz, 
1H), 2.59 (brq, J = 6.7 Hz, 2H), 2.44 (td, J = 7.1, 2.6 Hz, 2H), 2.34 (s, 3H), 2.03 (t, J =2.6 Hz, 1H); 13C 
NMR (101 MHz, CDCl3) δ 150.7, 146.0, 142.5, 141.5, 135.4, 133.0, 130.2, 127.0, 126.9, 125.2, 125.1, 
112.0, 118.6, 114.0, 83.2, 77.5, 77.2, 76.8, 69.5, 32.2, 21.7, 18.1; IR (film) υmax/cm
-1: 3295, 2920, 1644, 








(E)-2-(4-Chlorostyryl)-1-tosyl-1H-benzo[d]imidazole was synthesized following GP I using 0.68 mmol 
(250 mg) of N-boc protected benzimidazole phosphonate and 4-chlorobenzaldehyde (127.9 mg, 0.91 
mmol) as the aldehyde. CH2Cl2:Et3N 1:1 was used as a solvent for the N-tosylation. Purification by flash 
chromatography on silica gel (pentane to 4 pentane/1 EtOAc) afforded pure Bz11 as an off-white powder. 
(168 mg, 0.411 mmol, 61% overall yield). 
 
Mp : 168 °C (from EtOAc/Petrol); 1H NMR (400 MHz, CDCl3) δ 8.12 – 8.02 (m, 1H), 7.90 (d, J = 4.5 
Hz, 2H), 7.82 – 7.77 (m, 2H), 7.75 – 7.69 (m, 1H), 7.64 – 7.58 (m, 2H), 7.47 – 7.41 (m, 2H), 7.40 – 7.36 
(m, 2H), 7.25 (d, J = 8.1 Hz, 2H), 2.37 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 150.9, 146.1, 142.8, 138.4, 
135.5, 135.4, 134.4, 133.3, 130.3, 129.4, 129.0, 126.9, 125.5, 125.3, 120.1, 115.1, 114.1, 21.8; IR (film) 
υmax/cm
-1: 3057, 1512, 1490, 1447, 1378, 1344, 1200, 1185, 1168, 1150, 1090, 1051, 1013, 812, 764, 744, 







(E)-2-(4-Nitrostyryl)-1-tosyl-1H-benzo[d]imidazole was synthesized following GP I using 0.60 mmol 
(220 mg) of N-boc protected benzimidazole phosphonate using 4-nitrobenzaldehyde (120.9 mg, 0.8 
mmol) as the aldehyde. CH2Cl2:Et3N 1:1 was used as solvent for the N-tosylation. Purification by flash 
chromatography on silica gel (9 pentane/1 EtOAc to 7 pentane/3 EtOAc) afforded pure Bz12 as a yellow 
powder. (100 mg, 0.238 mmol, 35% overall yield). 
 
Mp : 194 °C (from EtOAc/Petrol); 1H NMR (400 MHz, CDCl3) δ 8.36 – 8.25 (m, 2H), 8.15 – 8.07 (m, 
2H), 7.98 (d, J = 15.9 Hz, 1H), 7.83 – 7.77 (m, 4H), 7.77 – 7.70 (m, 1H), 7.49 – 7.35 (m, 2H), 7.27 (d, J 
= 7.3 Hz, 2H), 2.38 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 150.0, 148.1, 146.4, 142.7, 142.1, 136.8, 
135.3, 133.3, 130.4, 128.3, 126.9, 125.9, 125.7, 124.5, 120.4, 118.9, 114.1, 21.8; IR (film) υmax/cm
-1: 







(E)-2-(3-Chlorostyryl)-1-tosyl-1H-benzo[d]imidazole was synthesized following GP I using 1.09 mmol 
(400 mg) of N-boc protected benzimidazole phosphonate and 3-chlorobenzaldehyde (205.0 mg, 1.46 
mmol). CH2Cl2:Et3N 1:1 was used as a solvent for the N-tosylation. Purification by flash chromatography 
on silica gel (8 pentane/2 EtOAc) afforded pure Bz13 as a colourless powder. (186 mg, 0.455 mmol, 42% 
overall yield). 
 
Mp : 126 °C (from EtOAc/Petrol);  1H NMR (400 MHz, CDCl3) δ 8.11 – 8.04 (m, 1H), 7.92 (d, J = 15.9 
Hz, 1H), 7.84 (d, J = 15.9 Hz, 1H), 7.80 – 7.75 (m, 2H), 7.72 – 7.67 (m, 1H), 7.62 (q, J = 1.4 Hz, 1H), 
7.55 – 7.49 (m, 1H), 7.41 – 7.32 (m, 4H), 7.25 – 7.19 (m, 2H), 2.35 (s, 3H); 13C NMR (101 MHz, CDCl3) 
δ 150.7, 146.2, 142.8, 138.3, 137.8, 135.4, 135.1, 133.3, 130.3 (d, J = 3.8 Hz), 129.6, 127.5, 126.9, 126.1, 
125.5 (d, J = 4.9 Hz), 120.2, 116.0, 114.1, 21.8; IR (film) υmax/cm
-1: 3060, 1594, 1511, 1497, 1378, 1343, 
1258, 1232, 1201, 1185, 1168, 1150, 1122, 1089, 1052, 782, 764, 744, 702, 690, 671, 645; HRMS (ESI+): 







(E)-1-Tosyl-2-(2-(6-(trifluoromethyl)pyridin-3-yl)vinyl)-1H-benzo[d]imidazole was synthesized 
following GP I using 0.68 mmol (250 mg) of N-boc protected benzimidazole phosphonate and 6-
(trifluoromethyl)nicotinaldehyde (159.4 mg, 0.91 mmol) as the aldehyde. CH2Cl2:Et3N 1:1 was used as a 
solvent for the N-tosylation. Purification by flash chromatography on silica gel (pentane to 8 pentane/2 
EtOAc) afforded pure Bz14 as an off-white powder. (151 mg, 0.341 mmol 51% overall yield). 
 
Mp : 158-160 °C (from EtOAc/Petrol); 1H NMR (400 MHz, CDCl3) δ 8.96 (d, J = 2.1 Hz, 1H), 8.17 – 
8.03 (m, 3H), 7.96 (d, J = 16.0 Hz, 1H), 7.78 (dd, J = 8.3, 4.6 Hz, 3H), 7.76 – 7.71 (m, 1H), 7.47 – 7.37 
(m, 2H), 7.28 (d, J = 7.6 Hz, 2H), 2.38 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 149.7, 149.5, 148.3 (q, J 
= 35.2 Hz), 146.4, 142.6, 135.3, 135.0, 134.4, 134.1, 133.3, 130.5, 126.9, 126.0, 125.7, 120.8 (d, J = 2.8 
Hz), 120.4, 119.1, 114.1, 21.8; 19F NMR (376 MHz, CDCl3) δ -67.9; IR (film) υmax/cm
-1: 3062, 1379, 










6/ General Procedures: 
 





To the corresponding organoazide (0.010 mmol) and tris(4-methoxyphenyl)phosphine (0.010 mmol) 
under argon atmosphere was added THF (0.2 mL) and the reaction mixture was stirred for 24 h. The 
formation of the organocatalysts was monitored by TLC. Upon completion volatiles were removed under 
a stream of N2 yielding the expected iminiphosphorane which was used without further purification. 
To the corresponding Michael acceptor (0.10 mmol) and BIMP organocatalyst (0.01 mmol) under argon 
atmosphere was added Et2O (1.60 mL) and thiol (0.12 mmol, 1.2 equivalents) then the reaction was stirred 
at 0 °C for 24 h. The reaction mixture was loaded directly onto silica gel and purified by flash column 
chromatography as specified in the individual experiment to afford pure sulfa-Michael addition product. 
The two enantiomers were separated by chiral HPLC using conditions specified in the individual 
experiment. 
 




To the corresponding Michael acceptor (0.10 mmol) and 2-tert-Butylimino-2-diethylamino-1,3-
dimethylperhydro-1,3,2-diazaphosphorine (BEMP) (3 µL, 0.010 mmol) under argon was added solvent 
(0.2 mL) and thiol (0.30 mmol) and the reaction was stirred at 22 °C for 24 h. Volatiles were removed 
under a stream of N2 and the crude product was purified by flash column chromatography as specified in 
the individual experiment to afford the racemic 1,4-addition product. The two enantiomers were separated 









Compound 2 was synthesized according to GPII from 1 (31.2 mg) using catalyst G and 1-propanethiol 
(9.1 mg, 11 µL) . Clear viscous oil (7 Petrol/ 3 EtOAc) (38.0 mg, 0.098 mmol, 98% yield, 95/5 er 
[determined by HPLC, Chiralpak AD-H, hexane/isopropanol = 95/5, 1 mL/min, λ = 220 nm, t (major) = 
16.63 min, t (minor) = 18.00 min])  
 
[α]D25 = -2.0 (c = 0.31, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 8.06 – 7.97 (m, 1H), 7.80 – 7.71 (m, 2H), 
7.69 – 7.63 (m, 1H), 7.37 – 7.28 (m, 2H), 7.27 – 7.18 (m, 2H), 3.62 – 3.44 (m, 2H), 3.33 – 3.20 (m, 1H), 
2.68 – 2.46 (m, 2H), 2.35 (s, 3H), 1.60 (h, J = 7.2 Hz, 2H), 1.35 – 1.27 (m, 3H), 0.95 (t, J = 7.3 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 152.8, 146.1, 142.1, 135.5, 133.1, 130.4, 126.9, 125.1, 124.9, 120.1, 113.9, 
38.5, 37.9, 33.0, 23.3, 21.8, 21.3, 13.7; IR (film) υmax/cm
-1: 2871, 1596, 1481, 1377, 1173, 1189, 765, 






Compound 3 was synthesized according to GPII from 1 (31.2 mg) using catalyst G using pentane-1-thiol 
(12.5 mg, 15 µL). Clear oil (7 Petrol/ 3 EtOAc) (32.7 mg, 0.078 mmol, 78% yield, 95/5 er [determined 
by HPLC, Chiralcel OG, hexane/isopropanol = 97/3, 1 mL/min, λ = 220 nm, t (minor) = 8.48 min, 
t (major) = 10.33 min]). 
 
[α]D25 = -3.7 (c = 0.48, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.08 – 7.93 (m, 1H), 7.82 – 7.71 (m, 2H), 
7.70 – 7.61 (m, 1H), 7.39 – 7.29 (m, 2H), 7.28 – 7.23 (m, 2H), 3.66 – 3.42 (m, 2H), 3.36 – 3.20 (m, 1H), 
2.71 – 2.49 (m, 2H), 2.37 (s, 3H), 1.66 – 1.51 (m, 2H), 1.41 – 1.20 (m, 7H), 0.87 (t, J = 7.1 Hz, 3H); 13C 
NMR (101 MHz, CDCl3) δ 152.8, 146.1, 142.1, 135.5, 133.1, 130.3, 126.9, 125.0, 124.8, 120.1, 113.9, 
38.5, 37.9, 31.3, 31.0, 29.6, 22.4, 21.8, 21.3, 14.1; IR (film) υmax/cm
-1: 2956, 2928, 2859, 1451, 1378, 









Compound 4 was synthesized according to a modified of GPII from 1 (31.2 mg) using catalyst G, 
propane-2-thiol (9.13 mg, 11 µL) and stirred at 22 °C. Clear viscous oil (7 Petrol/ 3 EtOAc) (29.8 mg, 
0.077 mmol, 78% yield, 94/6 er [determined by HPLC, Chiralpak AD-H, hexane/isopropanol = 95/5, 1 
mL/min, λ = 220 nm, t (major) = 15.60 min, t (minor) = 18.00 min]). 
 
[α]D25 = -7.5 (c = 0.58, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.06 – 7.95 (m, 1H),  7.82 – 7.74 (m, 2H), 
7.70 – 7.62 (m, 1H), 7.39 – 7.28 (m, 2H), 7.26 (dt, J = 7.3, 0.8 Hz, 2H), 3.66 – 3.55 (m, 1H), 3.50 (dd, J 
= 15.4, 5.2 Hz, 1H), 3.34 – 3.24 (m, 1H), 3.04 (p, J = 6.7 Hz, 1H), 2.38 (s, 3H), 1.35 – 1.27 (m, 6H), 1.24 
(d, J = 6.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 152.8, 146.1, 142.1, 135.5, 133.1, 130.3, 126.9, 125.0, 
124.8, 120.1, 113.9, 38.2, 37.3, 34.5, 24.1, 23.8, 21.8, 21.7; IR (film) υmax/cm
-1: 2960, 1541, 1337, 1293, 






Compound 5 was synthesized according to a modified version of GPII from 1 (31.2 mg) using catalyst 
G, cyclopentanethiol (12.3 mg, 13 µL) and stirred at 22 °C. Clear oil (7 Petrol/ 3 EtOAc) (37.7 mg, 0.091 
mmol, 91% yield, 95/5 er [determined by HPLC, Chiralcel OG, hexane/isopropanol = 97/3, 1 mL/min, λ 
= 220 nm, t (minor) = 10.11 min, t (major) = 11.28 min]). 
 
[α]D25 = -6.3 (c = 0.48, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.02 – 7.89 (m, 1H), 7.76 – 7.67 (m, 2H), 
7.64 – 7.55 (m, 1H), 7.31 – 7.22 (m, 2H), 7.21 – 7.12 (m, 2H), 3.60 – 3.44 (m, 2H), 3.29 – 3.05 (m, 2H), 
2.30 (s, 3H), 2.12 – 1.77 (m, 2H), 1.74 – 1.34 (m, 6H), 1.26 (d, J = 6.7 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ 152.9, 146.1, 142.0, 135.5, 133.1, 130.3, 126.9, 125.0, 124.8, 120.0, 113.8, 43.0, 38.5, 38.1, 
34.6, 34.3, 24.9, 21.8, 21.5; IR (film) υmax/cm
-1: 2957, 2960, 1541, 1377, 1293, 1149, 1089, 745, 667; 







Compound 6 was synthesized according to GPII  from 1 (31.2 mg) using catalyst G and 2-phenylethane-
1-thiol (16.6 mg, 16 µL). Pale yellow amorphous solid (7 Petrol/ 3 EtOAc) (42.1 mg, 0.093 mmol, 93% 
yield, 92.5/7.5 er [determined by HPLC, Chiralpak AD-H, hexane/isopropanol = 95/5, 1 mL/min, λ = 220 
nm, t (minor) = 27.01 min, t (major) = 28.93 min])  
 
[α]D25 = 6.9 (c = 0.71, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.08 – 8.01 (m, 1H) 7.78 (d, J = 8.4 Hz, 
2H), 7.73 – 7.66 (m, 1H), 7.41 – 7.32 (m, 2H), 7.32 – 7.17 (m, 7H), 3.70 – 3.51 (m, 2H), 3.32 (dd, J = 
15.0, 8.5 Hz, 1H), 3.01 – 2.75 (m, 4H), 2.38 (s, 3H), 1.38 (d, J = 6.7 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ 152.7, 146.1, 142.0, 140.7, 135.5, 133.1, 130.4, 128.6, 128.5, 126.8, 126.4, 125.1, 124.9, 120.1, 
113.9, 38.7, 37.9, 36.5, 32.4, 21.7, 21.3; IR (film) υmax/cm
-1: 2980, 1452, 1378, 1252, 1170, 1045, 668; 






Compound 7 was synthesized according to  GPII from 1 (31.2 mg) using catalyst G and 2-
(trimethylsilyl)ethane-1-thiol (16.1 mg, 19 µL). Clear oil (7 Petrol/ 3 EtOAc) (41.3 mg, 0.094 mmol, 94% 
yield, 96/4 er [determined by HPLC, Chiralcel AD-H , hexane/isopropanol = 95/5, 1 mL/min, λ = 220 
nm, t (minor) =  10.54 min, t (major) = 9.56 min]).  
 
[α]D25 = -11.1 (c = 0.82, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.09 – 7.99 (m, 1H), 7.84 – 7.77 (m, 2H), 
7.73 – 7.65 (m, 1H), 7.41 – 7.32 (m, 2H), 7.32 – 7.27 (m, 2H), 3.69 – 3.50 (m, 2H), 3.32 (dd, J = 15.1, 
8.5 Hz, 1H), 2.75 – 2.52 (m, 2H), 2.40 (s, 3H), 1.37 (d, J = 6.7 Hz, 3H), 0.99 – 0.77 (m, 2H), 0.01 (s, 9H); 
13C NMR (101 MHz, CDCl3) δ 152.9, 146.1, 142.0, 135.5, 133.2, 130.4, 126.9, 125.1, 124.9, 120.1, 113.9, 
38.5, 38.0, 26.7, 21.8, 21.2, 17.4, -1.7; IR (film) υmax/cm
-1: 2953, 1597, 1542, 1451, 1378, 1248, 1191, 
1171, 1149, 1090, 1044, 859, 745, 687, 666; HRMS (APCI +) calcd. for C₂₂H₃₁O₂N₂S₂Si [M+H]+ 







Compound 8 was synthesized according to GPII  from 1 (31.2 mg) using catalyst G and furan-2-
ylmethanethiol (13.7 mg, 12 µL). Clear oil (7 Petrol/ 3 EtOAc) (38.7 mg, 0.091 mmol, 91% yield, 89/11 
er [determined by HPLC, Chiralcel AD-H , hexane/isopropanol = 85/15, 1 mL/min, λ = 220 nm, t (minor) 
= 15.18 min, t (major) = 13.72 min]).  
 
[α]D25 = -27.5 (c = 0.83, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.04 – 7.97 (m, 1H), 7.82 – 7.73 (m, 2H), 
7.69 – 7.62 (m, 1H), 7.39 – 7.30 (m, 3H), 7.29 – 7.22 (m, 2H), 6.33 – 6.16 (m, 2H), 3.90 – 3.77 (m, 2H), 
3.65 – 3.56 (m, 1H), 3.55 – 3.46 (m, 1H), 3.36 – 3.25 (m, 1H), 2.37 (s, 3H), 1.34 (d, J = 6.7 Hz, 3H); 13C 
NMR (101 MHz, CDCl3) δ 152.6, 151.9, 146.1, 142.1, 142.1, 135.5, 133.1, 130.4, 126.9, 125.1, 124.9, 
120.1, 113.8, 110.6, 107.5, 38.9, 37.9, 27.9, 21.8, 21.1; IR (film) υmax/cm
-1: 2923, 1596, 1541, 1451, 1376, 
1233, 1191, 1170, 1149, 1121, 1089, 1045, 1012, 744, 703, 685, 666, 643; HRMS (APCI +) calcd. for 






Compound 9 was synthesized according to GPII from 1 (31.2 mg) using catalyst G and 
phenylmethanethiol (14.9 mg, 14 µL). Clear oil (7 Petrol/ 3 EtOAc) (41.2 mg, 0.089 mmol, 89% yield, 
89/11 er [determined by HPLC, Chiralpak AD-H, hexane/isopropanol = 95/5, 1 mL/min, λ = 220 nm, t 
(major) = 24.54 min, t (minor) = 29.98 min]). 
 
[α]D25 = -19.5 (c = 0.73, CHCl3) 1H NMR (400 MHz, CDCl3) δ 7.95 – 7.88 (m, 1H), 7.65 (d, J = 8.4 Hz, 
2H), 7.61 – 7.53 (m, 1H), 7.31 – 7.07 (m, 10H), 3.75 (d, J = 4.3 Hz), 3.54 – 3.42 (m, 2H), 3.28 – 3.13 (m, 
1H), 2.28 (s, 3H,), 1.24 (d, J = 6.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 152.6, 146.1, 142.0, 138.5, 
135.5, 133.1, 130.3, 128.9, 128.6, 127.0, 126.8, 125.0, 124.8, 120.1, 113.8, 38.9, 37.8, 35.7, 21.8, 21.3; 
IR (film) υmax/cm
-1: 3060, 3028, 2964, 1451, 1376, 1170, 1044, 643; HRMS (ESI +) calcd. for 








Compound 10 was synthesized according to GPII from 1 (31.2 mg) using catalyst G and (4-
methoxyphenyl)methanethiol (18.5 mg, 17 µL). Amorphous colourless solid (7 Petrol/ 3 EtOAc) (45.5 
mg, 0.098 mmol, 98% yield, 92/8 er [determined by HPLC, Chiralpak AD-H, hexane/isopropanol = 
85/15, 1 mL/min, λ = 220 nm, t (major) = 14.95 min, t (minor) = 18.30 min]). 
 
[α]D25 = -19.9 (c = 0.52, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.05 – 7.98 (m, 1H), 7.80 – 7.71 (m, 2H), 
7.70 – 7.62 (m, 1H), 7.40 – 7.29 (m, 2H), 7.29 – 7.16 (m, 4H), 6.85 – 6.76 (m, 2H), 3.78 (s + m, 5H), 
3.60 – 3.47 (m, 2H), 3.36 – 3.20 (m, 1H), 2.37 (s, 3H), 1.33 (d, J = 6.5 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ 158.6, 152.7 , 146.1, 142.1, 135.5, 133.1, 130.4, 130.3, 130.0, 125.1, 124.9, 120.1, 114.0, 113.9, 
55.4, 38.8, 37.9, 35.1, 21.8, 21.3; IR (film) υmax/cm
-1: 3023, 1541, 1500, 1451, 1376, 1171, 1013, 884, 






Compound 11 was synthesized according GP III from Bz2 (34.0 mg) using catalyst G, 1-propanethiol 
(9.1 mg, 11 µL). Clear oil (9 Pentane/ 1 EtOAc) (33.7 mg, 0.081 mmol, 81% yield, 86/14 er [determined 
by HPLC, Chiralcel AD-H, hexane/isopropanol = 95/5, 1 mL/min, λ = 220 nm, t (minor) = 22.89 min, 
t (major) = 21.24 min]). 
 
[α]D25 = -3.5 (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ = 7.78 (s, 1H), 7.75 (d, J = 8.4 Hz, 2H), 
7.41 (d, J = 0.9 Hz, 1H), 7.26 (dd, J = 8.5, 1.0 Hz, 2H), 3.56 – 3.44 (m, 2H), 3.27 – 3.18 (m, 1H), 2.63 – 
2.48 (m, 2H), 2.38 (s, 3H), 2.37 (s, 3H), 2.32 (s, 3H), 1.67 – 1.53 (m, 2H), 1.30 (d, J = 6.8 Hz, 4H), 0.97 
(t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 152.0, 145.9, 140.5, 135.8, 134.3, 133.8, 131.6, 
130.3, 126.7, 120.2, 114.1, 38.5, 37.9, 33.0, 23.3, 21.7, 21.2, 20.8, 20.3, 13.7; IR (film) υmax/cm
-1: 2962, 
2925, 1596, 1463, 1375, 1230, 1190, 1172, 1090, 1037, 811, 667; HRMS (ESI+): calcd. for C22H29O₂N₂S2 








Compound 12 was synthesized according GP III from Bz5 (39.1 mg) using catalyst G, 1-propanethiol 
(9.1 mg, 11 µL). Clear oil (95 Pentane/ 5 EtOAc) (36.0 mg, 0.077 mmol, 77% yield, 86/14 er [determined 
by HPLC, Chiralcel AD-H, hexane/isopropanol = 95/5, 1 mL/min, λ = 220 nm, t (minor) = 17.65 min, 
t (major) = 15.93 min]). 
 
[α]D25 = -5.9 (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.21 (d, J = 1.8 Hz, 1H), 7.78 (d, J = 8.4 
Hz, 2H), 7.52 (d, J = 8.6 Hz, 1H), 7.44 (dd, J = 8.5, 1.8 Hz, 1H), 7.31 (d, J = 7.8 Hz, 2H), 3.57 – 3.41 (m, 
2H), 3.24 (dd, J = 15.4, 8.5 Hz, 1H), 2.62 – 2.49 (m, 2H), 2.40 (s, 3H), 1.61 (h, J = 7.3 Hz, 3H), 1.32 (d, 
J = 6.5 Hz, 4H), 0.97 (t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 153.5, 146.5, 141.1, 135.3, 
134.1, 130.5, 128.3, 127.0, 121.2, 118.5, 117.0, 38.4, 37.9, 33.0, 23.3, 21.9, 21.4, 13.7; IR (film) υmax/cm
-
1: 2961, 2926, 1730, 1596, 1447, 1424, 1379, 1269, 1191, 1162, 1089, 1037, 939, 813, 708, 664; HRMS 
(ESI+): calcd. for C20H24O₂N₂BrS2 [M+H]






Compound 13 was synthesized according GP III from Bz6 (39.1 mg) using catalyst G, 1-propanethiol 
(9.1 mg, 11 µL). Clear oil (95 Pentane/ 5 EtOAc) (38.8 mg, 0.083 mmol, 81% yield, 84/16 er [determined 
by HPLC, Chiralcel AD-H, hexane/isopropanol = 95/5, 1 mL/min, λ = 220 nm, t (minor) = 19.17 min, 
t (major) = 20.44 min]). 
 
[α]D25 = -4.4 (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 8.7 Hz, 1H), 7.80 (d, J = 1.9 
Hz, 1H), 7.75 (d, J = 8.4 Hz, 2H), 7.45 (dd, J = 8.8, 1.9 Hz, 1H), 7.32 – 7.25 (m, 2H), 3.57 – 3.43 (m, 
2H), 3.32 – 3.20 (m, 1H), 2.64 – 2.47 (m, 2H), 2.39 (s, 3H), 1.68 – 1.54 (m, 3H), 1.33 (d, J = 6.8 Hz, 3H), 
0.97 (t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 154.1 , 146.5 , 143.4 , 135.3 , 132.2 , 130.5 , 
128.0 , 126.9 , 123.1 , 118.0 , 115.1 , 38.4 , 37.9 , 33.0 , 23.3 , 21.8 , 21.4 , 13.7; IR (film) υmax/cm
-1: 2921, 
2926, 1596, 1535, 1448, 1379, 1230, 1172, 1089, 1044, 910, 809, 705, 665; HRMS (ESI+): calcd. for 
C20H24O₂N₂BrS2 [M+H]








Compound 14 was synthesized according to a modified version of GPII from Bz3 (29.2 mg) using 
catalyst G, 3 equivalents of 1-propanethiol (22.8 mg, 0.3 mmol, 28 µL) and stirred at 22 °C. Clear oil (9 
Petrol/ 1 EtOAc) (22.3 mg, 0.061 mmol, 61% yield, 92.5/7.5 er [determined by HPLC, Chiralpak AS-H, 
hexane/isopropanol = 97/3, 1 mL/min, λ = 220 nm, t (minor) = 10.23 min, t (major) = 11.45 min]) 
 
[α]D25 = +2.0 (c = 0.40, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.92 – 7.83 (m, 1H), 7.75 – 7.65 (m, 1H) 
7.55 – 7.49 (m, 2H), 7.47 – 7.38 (m, 3H), 7.35 – 7.25 (m, 2H), 5.51 (d, J = 1.0 Hz, 2H), 3.63 (dd, J = 14.6, 
5.3 Hz, 1H), 3.47 – 3.36 (m, 1H), 3.31 (dd, J = 14.6, 8.8 Hz, 1H), 2.67 – 2.44 (m, 2H), 1.59 (h, J = 7.4 
Hz, 2H), 1.34 (d, J = 6.7 Hz, 3H), 0.96 (t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 154.3, 150.5, 
142.3, 134.3, 132.8, 129.3, 129.1, 129.0, 124.8, 124.6, 119.9, 115.2, 69.8, 38.9, 38.2, 32.7, 23.3, 21.4, 
13.7; IR (film) υmax/cm
-1: 2964, 1749, 1455, 1385, 1338, 1296, 1258, 1194, 1088, 1081, 746; HRMS 






Compound 15 was synthesized according to a modified version of GPII from Bz4 (25.8 mg) using 
catalyst G, 3 equivalents of 1-propanethiol (22.8 mg, 0.3 mmol, 28 µL) and stirred at 22 °C. Clear oil (8 
Petrol/ 2 EtOAc) (32.7 mg, 0.097 mmol, 97% yield, 91.5/8.5 er [determined by HPLC, Chiralpak AD-H, 
hexane/isopropanol = 97/3, 1 mL/min, λ = 220 nm, t (major) = 7.30 min, t (minor) = 6.61 min])  
 
[α]D25 = - 3.6 (c = 0.43, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.93 – 7.85 (m, 1H), 7.75 – 7.61 (m, 1H), 
7.35 – 7.27 (m, 2H), 3.64 (dd, J = 14.7, 5.3 Hz, 1H), 3.43 (ddd, J = 9.0, 6.8, 5.3 Hz, 1H, 3.30 (dd, J = 
14.7, 9.0 Hz, 1H), 2.66 – 2.46 (m, 2H), 1.72 (s, 9H), 1.60 (dt, J = 14.7, 7.4 Hz, 2H), 1.37 (d, J = 6.7 Hz, 
3H), 0.97 (t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 154.4, 149.1, 142.2, 137.7, 124.4, 124.2, 
119.8, 115.1, 85.7, 38.9, 38.1, 32.6, 28.2, 23.3, 21.3, 13.7 ; IR (film) υmax/cm
-1: 2970, 1745, 1454, 1341, 








Compound 16 was synthesized according GP III  from Bz7 (35.5 mg) using catalyst G, 1-propanethiol 
(9.1 mg, 11 µL). Clear oil (7 Pentane/ 3 EtOAc) (35.7 mg, 0.083 mmol, 83% yield, 93/7 er [determined 
by HPLC, Chiralcel AD-H, hexane/isopropanol = 95/5, 1 mL/min, λ = 220 nm, t (minor) = 13.39 min, 
t (major) = 22.26 min]). 
 
[α]D25 = -14.9 (c = 1.0, CHCl3). 1H NMR (400 MHz, CDCl3) δ = 8.06 – 7.98 (m, 1H), 7.78 (d, J = 8.4 
Hz, 2H), 7.70 – 7.64 (m, 1H), 7.41 – 7.30 (m, 2H), 7.27 (d, J = 8.4 Hz, 2H), 3.55 – 3.31 (m, 3H), 2.58 – 
2.42 (m, 2H), 2.38 (s, 3H), 1.66 – 1.49 (m, 5H), 1.38 – 1.22 (m, 3H), 0.93 (t, J = 7.3 Hz, 3H), 0.86 (t, J = 
7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 153.2, 146.1, 142.1, 135.7, 133.2, 130.3, 126.9, 125.0, 
124.8, 120.1, 113.9, 44.3, 36.9, 34.5, 33.1, 29.0, 23.3, 22.7, 21.8, 14.2, 13.7; IR (film) υmax/cm
-1: 2958, 
2928, 2871, 1451, 1377, 1237, 1189, 1177, 1148, 1120, 1089, 1045, 1014, 812, 765, 745, 703, 666, 623; 
HRMS (ESI+): calcd. for C₂₃H₃₁O₂N₂S₂ [M+H]+ 431.1820, found 431.1821. 
 




Compound 17 was synthesized according GP III from Bz8 (40.3 mg) using catalyst G, 1-propanethiol 
(9.1 mg, 11 µL). Clear oil (7 Pentane/ 3 EtOAc) (43.3 mg, 0.090 mmol, 90 % yield, 96/4 er [determined 
by HPLC, Chiralcel OG, hexane/isopropanol = 97/3 , 1 mL/min, λ = 220 nm, t (minor) = 13.04 min, 
t (major) = 15.69 min]). 
 
[α]D25 = -9.1 (c = 1.12, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.09 – 8.00 (m, 1H), 7.84 – 7.76 (m, 2H), 
7.74 – 7.64 (m, 1H), 7.43 – 7.32 (m, 2H), 7.31 – 7.24 (m, 4H), 7.23 – 7.13 (m, 3H), 3.66 – 3.56 (m, 1H), 
3.55 – 3.35 (m, 2H), 2.95 (ddd, J = 13.7, 10.7, 5.0 Hz, 1H), 2.83 – 2.66 (m, 1H), 2.66 – 2.48 (m, 2H), 
2.38 (s, 3H), 2.06 – 1.95 (m, 1H), 1.87 (dddd, J = 13.9, 10.7, 8.1, 5.0 Hz, 1H), 1.68 – 1.59 (m, 2H), 0.99 
(t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 152.8, 146.1, 142.1, 141.9, 135.6, 133.2, 130.3, 128.5, 
128.4, 126.8, 125.9, 125.0, 124.8, 120.1, 113.9, 43.9, 36.8, 36.3, 33.1, 33.0, 23.3, 21.8, 13.7; IR (film) 
υmax/cm
-1: 3026, 2960, 2925, 2870, 1597, 1452, 1190, 1176, 1147, 1121, 1089, 1047, 812, 765, 745, 701, 








Compound 18 was synthesized according GP III from Bz9 (36.6 mg) using catalyst G, 1-propanethiol 
(9.1 mg, 11 µL). Clear oil (8 Pentane/ 2 EtOAc) (34.1 mg, 0.077 mmol, 77% yield, 94.5/5.5 er [determined 
by HPLC, Chiralcel I-B, hexane/isopropanol = 98/2, 1 mL/min, λ = 220 nm, t (minor) = 8.41 min, 
t (major) = 8.87 min]). 
 
[α]D25 = -17.9 (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ = 8.05 – 7.98 (m, 1H), 7.77 (d, J = 8.4 
Hz, 2H), 7.69 – 7.64 (m, 1H), 7.37 – 7.29 (m, 2H), 7.26 (d, J = 8.6 Hz, 2H), 5.75 (ddt, J = 16.9, 10.2, 6.6 
Hz, 1H), 4.96 (dq, J = 17.1, 1.6 Hz, 1H), 4.90 (ddt, J = 10.2, 2.1, 1.1 Hz, 1H), 3.51 (dd, J = 14.0, 5.3 Hz, 
1H), 3.45 – 3.39 (m, 1H), 3.36 (dd, J = 14.6, 7.7 Hz, 1H), 2.59 – 2.41 (m, 2H), 2.37 (s, 3H), 2.05 – 1.98 
(m, 2H), 1.72 – 1.47 (m, 7H), 0.93 (t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 153.0, 146.1, 
142.1, 138.7, 135.6, 133.2, 130.3, 126.9, 125.0, 124.8, 120.9, 114.7, 113.9, 77.5, 77.2, 76.8, 44.1, 36.9, 
34.1, 33.6, 33.1, 26.1, 23.3, 21.8, 13.7; IR (film) υmax/cm
-1: 2930, 2859, 1735, 1452, 1378, 1247, 1177, 
1089, 1045, 745, 666; HRMS (ESI+): calcd. for C24H31O₂N₂S2 [M+H]






Compound 19 was synthesized according GP III  from Bz10 (35.0 mg) using catalyst G, 1-propanethiol 
(9.1 mg, 11 µL). Clear oil (8 Pentane/ 2 Et2O) (34.1 mg, 0.080 mmol, 80% yield, 96/4 er [determined by 
HPLC, Chiralcel AD-H, hexane/isopropanol = 97/3, 1 mL/min, λ = 220 nm, t (minor) = 35.17 min, 
t (major) = 37.67 min]). 
 
[α]D25 = -17.8 (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ =8.04 – 7.97 (m, 1H), 7.78 (d, J = 8.4 Hz, 
2H), 7.69 – 7.65 (m, 1H), 7.38 – 7.30 (m, 2H), 7.27 (d, J=7.7, 2H), 3.56 (dd, J = 14.5, 6.2 Hz, 1H), 3.53 
– 3.46 (m, 1H), 3.38 (dd, J = 14.5, 7.2 Hz, 1H), 2.61 – 2.46 (m, 2H), 2.45 – 2.34 (m+s, 5H), 2.00 – 1.89 
(m, 1H), 1.93 (t, J = 2.6 Hz, 1H), 1.80 – 1.71 (m, 1H), 1.58 (dqd, J = 14.7, 7.2, 1.8 Hz, 2H), 0.93 (t, J = 
7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 152.5, 146.1, 142.1, 135.5, 133.2, 130.4, 126.9, 125.9, 
124.9, 120.2, 113.9, 83.9, 77.5, 77.2, 76.8, 68.9, 43.5, 36.9, 33.5, 33.2, 29.8, 23.3, 21.8, 16.3, 13.7; IR 
(film) υmax/cm
-1: 3298, 3058, 2960, 2923, 2852, 1596, 1540, 1451, 1376, 1189, 1047, 765, 666; HRMS 
(ESI+): calcd. for C23H27O₂N₂S2 [M+H]







Compound 20 was synthesized according to a modified version of GPII from Bz1 (37.4 mg) using 
catalyst F, 1-propanethiol (22.8 mg, 11 µL) in THF (1.6 mL) and stirred at 22 °C. Amorphous white solid 
(Petrol 7/ 3 EtOAc) (39.1 mg, 0.087 mmol, 87% yield, 88/12 er [determined by HPLC, Chiralpak AD-H, 
hexane/isopropanol = 97/3, 1 mL/min, λ = 220 nm, t (major) = 42.23 min, t (minor) = 62.91 min]). 
 
[α]D25 = +5.8 (c = 0.79, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.93 – 7.90 (m, 1H), 7.68 – 7.66 (m, 2H), 
7.65 – 7.58 (m, 1H), 7.43 – 7.36 (m, 2H), 7.33 – 7.11 (m, 7H), 4.71 (t, J = 7.5 Hz, 1H), 3.88 – 3.62 (m, 
2H), 2.33 (s, 3H), 2.32 – 2.17 (m, 2H), 1.54 – 1.37 (m, 2H), 0.83 (t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ 152.1, 146.0, 142.1, 142.0, 135.5, 133.1, 130.3, 128.6, 128.0, 127.3, 126.9, 125.0, 124.8, 120.2, 
113.8, 47.6, 37.2, 33.6, 22.7, 21.8, 13.6; IR (film) υmax/cm
-1: 2981, 1627, 1597, 1449, 1378, 1378, 1149, 






Compound 21 was synthesized according GP III from Bz11 (40.9 mg) using catalyst G, 1-propanethiol 
(22.8 mg, 11 µL) in THF (1.6 mL) and stirred at 22 °C. Clear oil (8 Pentane/ 2 EtOAc) (29.6 mg, 0.061 
mmol, 61% yield, 91/9 er [determined by HPLC, Chirapak AD-H, hexane/isopropanol = 95/5, 1 mL/min, 
λ = 220 nm, t (minor) = 28.80 min, t (major) = 22.55 min]). 
 
[α]D25 = +12.3 (c = 0.32, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.99 – 7.91 (m, 1H), 7.67 (d, J = 8.5 
Hz, 2H), 7.67 – 7.59 (m, 1H), 7.38 – 7.28 (m, 4H), 7.27 – 7.17 (m, 4H), 4.70 (dd, J = 8.1, 7.0 Hz, 1H), 
3.70 (qd, J = 15.9, 7.5 Hz, 2H), 2.38 (s, 3H), 2.31 (td, J = 7.8, 6.8 Hz, 2H), 1.66 – 1.40 (m, 2H), 0.88 (t, 
J = 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 151.8, 146.1, 142.0, 140.6, 135.5, 133.1, 132.9, 130.4, 
129.5, 128.7, 126.8, 125.1, 124.9, 120.2, 113.8, 46.9, 37.2, 33.7, 22.7, 21.8, 13.6; HRMS (APCI+): calcd. 








Compound 22 was synthesized according GP III from Bz12 (41.9 mg) using catalyst G, 1-propanethiol 
(22.8 mg, 11 µL) in THF (1.6 mL) and stirred at 22 °C. Yellow oil (8 Pentane/ 2 EtOAc) (33.4 mg, 0.067 
mmol, 67% yield, 88/12 er [determined by HPLC, Chirapak AD-H, hexane/isopropanol = 80/20, 1 
mL/min, λ = 220 nm, t (minor) = 12.69 min, t (major) = 16.93 min]). 
 
[α]D25 = +15.7 (c = 1.21, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.10 – 8.08 (m, 2H), 8.01 – 7.95 (m, 
1H), 7.76 – 7.70 (m, 2H), 7.67 – 7.61 (m, 1H), 7.60 – 7.55 (m, 2H), 7.34 (ddd, J = 7.0, 5.0, 1.7 Hz, 2H), 
7.28 (dd, J = 8.9, 1.0 Hz, 2H), 4.83 (dd, J = 8.4, 6.8 Hz, 1H), 3.84 – 3.67 (m, 2H), 2.39 (s, 3H), 2.38 – 
2.23 (m, 2H), 1.65 – 1.41 (m, 2H), 0.91 (t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 151.1, 149.8, 
147.1, 146.3, 141.8, 135.4, 133.1, 130.4, 129.0, 126.8, 125.3, 125.0, 123.8, 120.2, 113.8, 46.9, 36.8, 33.8, 
22.6, 21.8, 13.5; IR (film) υmax/cm
-1: 2962, 2929, 1596, 1519, 1451, 1371, 1349, 1189, 1049, 745, 668; 






Compound 23 was synthesized according GP III  from Bz13 (40.1 mg) using catalyst G, 1-propanethiol 
(22.8 mg, 11 µL) in THF (1.6 mL)  and stirred at 22 °C. Clear oil (7 Pentane/ 3 EtOAc) (29.9 mg, 0.062 
mmol, 62% yield, 93/7 er [determined by HPLC, Chiralpak AD-H hexane/isopropanol = 90/10, 1 mL/min, 
λ = 220 nm, t (minor) =17.19 min, t (major) = 11.32 min]). 
 
[α]D25 = +17.1 (c = 0.66, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.00 – 7.94 (m, 1H), 7.75 – 7.69 (m, 
2H), 7.67 – 7.61 (m, 1H), 7.42 – 7.38 (m, 1H), 7.34 – 7.28 (m, 3H), 7.25 (m, 2H), 7.22 – 7.10 (m, 2H), 
4.70 (t, J = 7.5 Hz, 1H), 3.71 (t, J = 7.6 Hz, 2H), 2.37 (s, 3H), 2.34 – 2.20 (m, 2H), 1.55 – 1.44 (m, 2H), 
0.87 (t, J = 7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 151.7, 146.1, 144.3, 142.0, 135.5, 134.4, 133.2, 
130.4, 129.8, 128.1, 127.6, 126.8, 126.4, 125.1, 124.8, 120.2, 113.8, 47.0, 37.1, 33.7, 22.6, 21.8, 13.6. IR 
(film) υmax/cm
-1: 3058, 2961, 1596, 1452, 1377, 1189, 1089, 1048, 765, 668; HRMS (APCI+): calcd. for 








Compound 24 was synthesized according GP III from Bz14 (44.3 mg) using catalyst G, 1-propanethiol 
(22.8 mg, 11 µL) in THF (1.6 mL) and stirred at 22 °C. Clear oil (8 Pentane/ 2 EtOAc) (38.4 mg, 0.074 
mmol, 74% yield, 90/10 er [determined by HPLC, Chiralpak IA, hexane/isopropanol = gradient 995/005 
to 70/30, 1 mL/min, λ = 220 nm, t (minor) = 41.05 min, t (major) = 42.29 min]). 
 
[α]D25 = +13.2 (c = 0.54, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.74 (d, J = 2.1 Hz, 1H), 7.99 (ddd, J = 
7.9, 1.9, 1.0 Hz, 2H), 7.75 – 7.68 (m, 2H), 7.66 – 7.59 (m, 2H), 7.35 (ddd, J = 7.0, 4.8, 1.7 Hz, 2H), 7.28 
(dd, J = 8.6, 1.0 Hz, 2H), 4.83 (dd, J = 8.3, 6.8 Hz, 1H), 3.78 (dd, J = 7.6, 4.0 Hz, 2H), 2.40 (s, 3H), 2.39 
– 2.26 (m, 2H), 1.65 – 1.47 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 150.8, 
150.1, 147.0 (q, J = 34.6 Hz), 146.4, 141.8, 141.3, 136.8, 135.4, 133.1, 130.5, 126.7, 125.4, 125.0, 120.4 
(d, J = 2.6 Hz), 120.2, 113.8, 44.3, 36.8, 33.8, 22.6, 21.8, 13.5; 19F NMR (376 MHz, CDCl3) δ -67.8; IR 
(film) υmax/cm
-1: 3057, 2963, 2931, 1452, 1378, 1337, 1174, 1137, 1088, 1051, 745, 669; HRMS 









To a solution of 2 (50 mg, 0.129 mmol) in THF (1 mL) was added 5 M aq. HCl (1 mL). The mixture was 
stirred at 40°C for 10 h. The reaction was quenched with a solution of saturated NaHCO3 and the aqueous 
phase extracted twice with EtOAc (5 mL). The combined organics were washed with brine, dried over 
MgSO4 and concentrated under vaccum. The residue was purified by flash chromatography with pure 
EtOAc affording product 25 as a white solid (30.2 mg, 0.129 mmol, 100% yield and 95.5/4.5 er) 
[determined by HPLC, Chiralcel OD-H, hexane/isopropanol = 95/5, 1 mL/min, λ = 220 nm, t (minor) = 
33.17 min, t (major) = 41.12 min]). 
 
Mp : 94°C (from EtOAc); [α]D25 = -38.9 (c = 0.4, CHCl3); 1H NMR (400 MHz, MeOD) δ =7.48 (dd, J = 
6.1, 3.2 Hz, 2H), 7.18 (dd, J = 6.1, 3.2 Hz, 2H), 4.87 (s, 2H), 3.34 – 3.23 (m, 2H), 3.14 (dd, J = 14.3, 6.7 
Hz, 1H), 2.97 (dd, J = 14.4, 8.0 Hz, 1H), 2.48 (td, J = 7.2, 3.5 Hz, 2H), 1.55 (h, J = 7.3 Hz, 2H), 1.27 (d, 
J = 6.8 Hz, 3H), 0.91 (t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, MeOD) δ = δ 152.4, 121.3, 113.4, 38.2, 
36.2, 31.6, 22.1, 19.8, 11.7; IR (film) υmax/cm
-1: 3054, 2959, 2869, 1538, 1453, 1437, 1376, 1272, 1026, 
742; HRMS (ESI+): calcd. for C13H19N₂S [M+H]








To a solution of 2 (40 mg, 0.103 mmol) in CH2Cl2 (1 mL) at 22 °C was added m-CPBA (77% in water) 
(53 mg, 0.236 mmol). The mixture was stirred for 4h. The reaction was diluted with CH2Cl2 (5 ml) and 
quenched with a solution of saturated Na2S2O3. The organic layer was washed with a solution of saturated 
NaHCO3, dried over MgSO4 and concentrated under reduced pressure. The residue was purified by flash 
chromatography on silica gel (6 Et2O/ 4 pentane) affording the pure compound 26 as a colorless oil (41.1 
mg, 0.098 mmol, 95% yield and 95/5 er [determined by HPLC, Chiralcel AD-H, hexane/ isopropanol = 
90/10, 1 mL/min, λ = 220 nm, t (minor) = 37.12 min, t (major) = 49.98 min]). 
 
[α]D25 = -1.8 (c = 1.7, CHCl3); 1H NMR (400 MHz, CDCl3) δ = 8.06 – 8.01 (m, 1H), 7.82 (d, J = 8.4 Hz, 
2H), 7.68 – 7.62 (m, 1H), 7.41 – 7.32 (m, 2H), 7.30 (d, J = 7.8 Hz, 2H), 3.97 (dqd, J = 9.6, 6.9, 3.8 Hz, 
1H), 3.86 (dd, J = 16.5, 3.8 Hz, 1H), 3.37 (dd, J = 16.5, 9.6 Hz, 1H), 3.06 – 2.92 (m, 2H), 2.38 (s, 3H), 
2.01 – 1.84 (m, 2H), 1.47 (d, J = 6.9 Hz, 3H), 1.07 (t, J = 7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 
150.6, 146.5, 141.8, 135.1, 133.3, 130.6, 127.0, 125.5, 125.0, 120.1, 113.8, 55.3, 52.4, 30.0, 21.8, 15.6, 
13.6, 13.4; IR (film) υmax/cm
-1: 2971, 1596, 1541; 1452, 1376, 1292, 1170, 1122, 1088, 746, 668; HRMS 
(ESI+): calcd. for C20H25O4N₂S2 [M+H]









A procedure from the literature9 was modified as follows. To a solution of 10 (45 mg, 0.095 mmol, 91/9 
er) in TFA (621 µL) was added anisole (72 µL, 0.66 mmol) and was stirred at 65°C for 4 hrs. Volatiles 
were then removed under a stream of N2 and the resulting crude was dissolved in Et2O (1.6 mL) and 
passed through a plug of K2CO3. The resulting solution was loaded directly onto silica gel (7 Petrol/ 3 
EtOAc) to afford pure 27 as a clear oil (16.1 mg, 0.048 mmol, 50% yield, 91/9 er [determined by HPLC, 
Chiralcel AD-H, hexane/ isopropanol = 95/5, 1 mL/min, λ = 220 nm, t (minor) = 19.00 min, t (major) = 
22.53 min]). 
 
[α]D25 = +3.9 (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.03 – 7.98 (m, 1H), 7.82 – 7.77 (m, 2H), 
7.71 – 7.65 (m, 1H), 7.39 – 7.31 (m, 2H), 7.30 – 7.27 (m, 2H), 3.79 – 3.68 (m, 1H), 3.51 – 3.37 (m, 2H), 
2.38 (s, 3H), 2.04 (dd, J = 6.5, 0.5 Hz, 1H), 1.47 (dd, J = 6.5, 0.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) 
δ 152.6, 146.2, 142.1, 135.5, 133.1, 130.4, 126.9, 125.2, 124.9, 120.2, 113.8, 41.5, 33.5, 24.7, 21.8; IR 
(film) υmax/cm
-1: 2968, 2923, 1452, 1378, 1254, 1232, 1170, 1089, 1048, 746, 668; HRMS (APCI+): 
calcd. for C₁₇H₁₉O₂N₂S₂ [M+H]+ 347.0883, found 347.0880. 
 
  
                                                 
 
9 Y. Liu, B. Sun, B. Wang, M. Wakem, and L. Deng, J. Am. Chem. Soc., 2009, 131, 418. 
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To a mixture of crotonic acid (2.68 g, 30.0 mmol) in polyphosphoric acid (12 g) was added 3-
methylbenzene-1,2-diamine (3.66 g, 30.0 mmol). The reaction was heated at 180 °C for 12 h. The mixture 
was cooled down to 22 °C and poured carefully onto a saturated solution of NaHCO3. Solid NaHCO3 was 
added until neutral pH was obtained. The solution was diluted with EtOAc and water then stirred 
vigorously for 10 min. The aqueous phase was extracted twice with EtOAc and the combined organic 
phase were washed with brine, dried over MgSO4 and concentrated under vacuum affording 4.06 g of 
crude light brown solid. 
The crude residue (2.49 g, 14.5 mmol) was dissolved in CH2Cl2 (35.0 mL), NEt3 (35.0 mL) was added 
then TsCl (3.01 g, 16.0 mmol). The mixture was stirred for 24h at 22 °C. The solvent was removed under 
vacuum and the crude was purified by flash chromatography on silica gel (CH2Cl2). A subsequent 
trituration in pentane afforded pure (E)-4-methyl-2-(prop-1-en-1-yl)-1-tosyl-1H-benzo[d]imidazole (3.76 
g, 11.5 mmol, 79% yield) as a colourless solid. 
 
Mp : 178°C (from CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.88 (d, J = 8.2 Hz, 1H), 7.76 (d, J = 1.7 Hz, 
2H), 7.26 – 7.19 (m, 4H), 7.16 – 7.06 (m, 2H), 2.59 (s, 3H), 2.35 (s, 3H), 2.05 (dd, J = 6.8, 1.7 Hz, 3H); 
13C NMR (126 MHz, CDCl3) δ 150.3, 145.7, 141.7, 139.1, 135.5, 132.6, 130.0, 129.9, 126.8, 125.5, 
124.6, 118.8, 111.3, 21.6, 19.0, 16.5; IR (film) υmax/cm
-1: 2980, 1597, 1517, 1445, 1374, 1339, 1203, 





Compound 29 was synthesized according to a modified version of GPII from 28 (31.2 mg) using catalyst 
G, 3 equivalents of 1-propanethiol (22.8 mg, 0.3 mmol, 28 µL) and stirred at 22 °C in 0.6 mL of THF. 
Clear viscous oil (7 Petrol/ 3 EtOAc) (24.1 mg, 0.060 mmol, 60% yield, 50/50 er [determined by HPLC, 
Chiralpak IC, hexane/isopropanol = 99/1, 1 mL/min, λ = 220 nm, t (major) = 16.69 min, t (minor) = 19.91 
min])  
1H NMR (400 MHz, CDCl3) δ 7.82 (dt, J = 8.2, 0.9 Hz, 1H), 7.80 – 7.72 (m, 2H), 7.29 – 7.23 (m, 3H), 
7.21 (d, J = 7.9 Hz, 1H), 7.12 (dt, J = 7.5, 1.0 Hz, 1H), 3.65 – 3.47 (m, 2H), 3.34 – 3.22 (m, 1H), 2.67 – 
2.48 (s + m, 5H), 2.37 (s, 3H), 1.63 (h, J = 7.2 Hz, 2H), 1.35 (d, J = 6.6 Hz, 3H), 0.97 (t, J = 7.3 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 152.0, 145.9, 141.3, 135.8, 132.9, 130.3, 130.2, 126.9, 125.4, 124.8, 
111.3, 38.6, 38.1, 33.0, 23.3, 21.8, 21.4, 16.6, 13.7; IR (film) υmax/cm
-1: 2962, 2925, 2871, 1374, 1190, 
1186, 1103, 1012, 812, 778, 766, 703, 678, 648; HRMS (ESI+): calcd. for C₂₁H₂₇O₂N₂S₂ [M+H]+ 














11/ 1H and 13C NMR spectra  






































































































































































































































































































































































































































































# Time Area Height Width Area% 
1 16.157 24223.5 1048.9 0.3494 49.832 




# Time Area Height Width Area% 
1 16.621 48256.6 1944.9 0.3755 94.870 









# Time Area Height Width Area% 
1 8.483 31084.0 927.7141 0.5149 49.864 
2 10.334 31254.6 645.9370 0.7345 50.136 
 
 Enantioenriched product 
 
# Time Area Height Width Area% 
1 8.903 1339.9 38.2640 0.5366 4.636 










# Time Area Height Width Area% 
1 14.306 1649.7 72.7986 0.3384 50.052 




# Time Area Height Width Area% 
1 15.604 21620.1 922.3245 0.3535 93.202 










# Time Area Height Width Area% 
1 9.986 15351.7 383.4876 0.6190 49.182 




# Time Area Height Width Area% 
1 10.109 2658.4 71.6780 0.5827 4.764 











# Time Area Height Width Area% 
1 27.022 17032.2 429.5468 0.6026 49.755 




# Time Area Height Width Area% 
1 27.059 2723.8 69.5989 0.5926 6.351 









# Time Area Height Width Area% 
1 9.602 6850.8 495.3327 0.2074 49.918 
2 10.610 6873.3 443.6841 0.2327 50.082 
 
 Enantioenriched product 
 
# Time Area Height Width Area% 
1 9.557 1134.6 83.2183 0.2051 4.002 










# Time Area Height Width Area% 
1 13.932 17002.3 818.9419 0.6141 49.852 




# Time Area Height Width Area% 
1 13.724 27589.1 818.9419 0.3115 89.106 









# Time Area Height Width Area% 
1 24.536 42477.2 1184.4417 0.5424 49.978 
2 29.964 42515.1 952.5371 0.6727 50.022 
 
 Enantioenriched product 
 
# Time Area Height Width Area% 
1 24.592 89767.9 2418.4070 0.5651 88.989 









# Time Area Height Width Area% 
1 15.363 62104.3 2568.3023 0.3701 49.691 




# Time Area Height Width Area% 
1 14.949 58773.1 2465.8980 0.3661 91.193 









# Time Area Height Width Area% 
1 21.467 1.55473e4 505.28189 0.4670 49.6855 




# Time Area Height Width Area% 
1 21.246 2.17454e4 673.19257 0.4849 86.2196 









# Time Area Height Width Area% 
1 15.969 3.43880e4 1475.41064 0.3559 48.7907 





# Time Area Height Width Area% 
1 14.364 206.9619 399.40341 0.3449 85.8882 









# Time Area Height Width Area% 
1 19.398 1.24443e4 442.41595 0.4282 49.7842 




# Time Area Height Width Area% 
1 19.179 7845.54053 296.33978 0.4009 15.8078 










# Time Area Height Width Area% 
1 10.486 52056.1 2079.6 0.3880 49.664 




# Time Area Height Width Area% 
1 10.227 2339.1 106.8 0.3335 7.338 









# Time Area Height Width Area% 
1 6.636 32821.6 2836.5 0.1790 49.600 





# Time Area Height Width Area% 
1 6.610 1767.4 168.3 0.1585 8.295 








# Time Area Height Width Area% 
1 12.309 8994.98633 510.45645 0.2656 49.3848 




# Time Area Height Width Area% 
1 12.262 1.87781e4 1011.44312 0.2786 93.1804 









# Time Area Height Width Area% 
1 12.675 10457.9 173.8140 0.9179 50.063 




# Time Area Height Width Area% 
1 13.040 1212.1 19.0291 0.9811 4.666 








# Time Area Height Width Area% 
1 8.366 6081.06592 499.22632 0.1821 48.9965 




# Time Area Height Width Area% 
1 8.414 563.17572 51.41105 0.1826 5.4142 







# Time Area Height Width Area% 
1 34.562 2.34292e4 459.58228 0.7708 49.8764 




# Time Area Height Width Area% 
1 35.171 1776.26453 35.18375 0.7650 3.9900 






Racemic product  
 
# Time Area Height Width Area% 
1 38.861 9754.6 160.4723 0.9252 50.252 




# Time Area Height Width Area% 
1 42.248 10133.4 158.0832 0.9679 89.967 









# Time Area Height Width Area% 
1 21.611 20460.5 517.2202 0.5955 50.037 




# Time Area Height Width Area% 
1 22.546 32986.8 785.3682 0.6300 90.856 








# Time Area Height Width Area% 
1 17.303 22852.9 662.3140 0.5166 50.125 




# Time Area Height Width Area% 
1 16.932 8521.5 267.1431 0.4821 87.486 








# Time Area Height Width Area% 
1 11.062 14813.3 786.5033 0.2837 49.895 




# Time Area Height Width Area% 
1 10.878 9806.3 537.7 0.2768 92.8014 






Racemic product  
 
# Time Area Height Width Area% 
1 39.832 12715.0 408.8265 0.5184 49.831 




# Time Area Height Width Area% 
1 41.045 1692.3 54.7341 0.4767 10.432 








# Time Area Height Width Area% 
1 32.885 9137.54688 82.40344 1.6617 50.0216 




# Time Area Height Width Area% 
1 33.177 668.35852 6.28705 1.2762 4.2485 








# Time Area Height Width Area% 
1 40.184 3.11824e4 419.67453 1.1108 49.9185 




# Time Area Height Width Area% 
1 37.121 5.29723e4 743.85822 1.0648 95.1836 









# Time Area Height Width Area% 
1 19.995 5018.7 164.5 0.4560 49.8617 






# Time Area Height Width Area% 
1 19.007 1415.6 47.77 0.4417 8.755 
2 22.527 14753.6 350.1 0.6157 91.245 
 
13/ Single Crystal X-Ray Diffraction Data 
 









Chemical formula C13H18N2S 
Mr 234.37 
Crystal system, space group Orthorhombic, P21212 
Temperature (K) 150 
a, b, c (Å) 20.7206 (4), 9.8606 (2), 6.3486 (1) 
V (Å3) 1297.13 (4) 
Z 4 
Radiation type Cu Kα 
µ (mm−1) 2.00 
Crystal size (mm) 0.20 × 0.20 × 0.15 
Data collection 
Diffractometer Unknown 
Absorption correction Multi-scan  
DENZO/SCALEPACK (Otwinowski & Minor, 1997) 
Tmin, Tmax 0.42, 0.74 
S99 
 
No. of measured, independent 
and 
observed [I > 2.0σ(I)] 
reflections 
26964, 2686, 2630 
Rint 0.047 
(sin θ/λ)max (Å−1) 0.630 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.037, 0.108, 0.99 
No. of reflections 2686 
No. of parameters 155 
No. of restraints 8 
H-atom treatment H atoms treated by a mixture of independent and constrained 
refinement 
Δρmax, Δρmin (e Å−3) 0.33, −0.34 
Absolute structure Flack (1983), 1104 Friedel-pairs 
Absolute structure parameter 0.01 (2) 
Computer programs: USER DEFINED DATA COLLECTION, USER DEFINED CELL REFINEMENT, USER DEFINED DATA 
REDUCTION, SIR92 (Altomare et al., 1994), CRYSTALS(Betteridge et al., 2003), CAMERON (Watkin et al., 1996). 
Table 2 
Selected geometric parameters (Å, º) 
S1—C2 1.8212 (16) C6—C11 1.394 (2) 
S1—C14 1.821 (2) C7—C8 1.377 (3) 
C2—C3 1.538 (2) C8—C9 1.388 (3) 
C2—C13 1.511 (3) C9—C10 1.383 (3) 
C3—C4 1.490 (2) C10—C11 1.398 (3) 
C4—N5 1.332 (2) C11—N12 1.389 (3) 
C4—N12 1.338 (2) C14—C15 1.527 (3) 
N5—C6 1.390 (3) C15—C16 1.491 (4) 
C6—C7 1.398 (3)   
C2—S1—C14 104.02 (9) C7—C6—C11 121.5 (2) 
S1—C2—C3 104.10 (10) C6—C7—C8 116.6 (2) 
S1—C2—C13 113.04 (15) C7—C8—C9 122.2 (3) 
C3—C2—C13 112.10 (18) C8—C9—C10 121.7 (3) 
C2—C3—C4 113.54 (13) C9—C10—C11 116.8 (2) 
C3—C4—N5 123.70 (19) C10—C11—C6 121.2 (2) 
C3—C4—N12 123.28 (18) C10—C11—N12 131.34 (19) 
N5—C4—N12 113.02 (13) C6—C11—N12 107.46 (18) 
C4—N5—C6 106.14 (15) C11—N12—C4 105.98 (15) 
N5—C6—C7 131.08 (18) S1—C14—C15 109.75 (16) 




Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A 
N5—H51···N5i 0.85 1.98 2.792 (3) 161 (2) 
N12—H121···N12ii 0.86 1.98 2.801 (3) 162 (5) 
Symmetry codes: (i) −x+1, −y+1, z; (ii) −x+1, −y, z. 
Alert level C 
 
PLAT250_ALERT_2_C Large U3/U1 Ratio for Average U(i,j) Tensor ....        2.6 Note   
 




14/ Computational Methods 
 
The range-separated dispersion-corrected ωB97X-D density functionali,ii was used with the 6-31G(d) 
basis set to optimize geometries. Vibrational frequency calculations were carried out to confirm that 
stationary points were either minima or first-order saddle points on the potential energy surface, and to 
obtain thermal corrections to Gibbs free energies at 298.15 K (80 ̊ C). Quasi-harmonic (QHA) corrections 
were applied to the computed vibrational entropies using a frequency cut-off value of 100.0 cm-1, adopting 
the model proposed by Grimme.iii This was automated by the GoodVibes program.iv 
Vibrational frequency calculations were carried out to confirm that stationary points were either minima 
or first-order saddle points on the potential energy surface, and to obtain thermal corrections to Gibbs free 
energies at 353.15 K (80 ˚C). Quasi-harmonic (QHA) corrections were applied to the computed 
vibrational entropies using a frequency cut-off value of 100.0 cm-1, adopting the model proposed by 
Grimme.v This was automated by the GoodVibes program.vi Solvent effects were considered using the 
integral equation formalism variant of the polarizable continuum model (IEF-PCM)vii,viii,ix,x,xi with the 
SMD solvation model (solvent=ethanol).xii Density functional theory (DFT) calculations were carried out 
in Gaussian 09.xiii 
 
Figure S1. Comparison of ‘mode A’ and ‘mode B’ transition structures leading the major enantiomeric product. Mode A is 
favored by several kcal/mol using either wB97XD or M06-2X functionals. 
 
Cartesian Coordinates (xyz format): 
136 
mode A TS (E = -4263.576613 H) 
C    -1.126728    -2.730766     0.944321 
N    -0.007387    -1.837566     1.158652 
H     0.780734    -1.945485     0.532640 
S102 
 
C    -0.070408    -0.683240     1.868412 
S    -1.499399    -0.202053     2.666146 
N     1.079709     0.015110     1.905089 
H     1.931533    -0.424272     1.534365 
C     1.218856     1.383877     2.378892 
H     0.209980     1.712905     2.639152 
H     1.177054     1.803527    -0.799539 
C     1.723846     2.243898     1.210007 
N     0.799005     2.236325     0.074436 
H     2.670389     1.846266     0.837006 
P    -0.253350     3.458853    -0.207747 
C     0.566197     4.936354    -0.852937 
C     1.793344     4.765370    -1.501702 
C    -0.010260     6.208858    -0.765937 
C     2.439858     5.863106    -2.059835 
H     2.236992     3.776224    -1.580900 
C     0.640958     7.301169    -1.328736 
H    -0.960717     6.350653    -0.259584 
C     1.864760     7.128364    -1.972947 
H     3.391805     5.726403    -2.563381 
H     0.193429     8.287805    -1.260857 
H     2.369937     7.984361    -2.410275 
C    -1.085940     3.897989     1.326436 
C    -0.542886     4.844802     2.203309 
C    -2.248565     3.204474     1.672516 
C    -1.171035     5.097335     3.417503 
H     0.363799     5.382982     1.942934 
C    -2.871916     3.464548     2.887147 
H    -2.656575     2.457664     0.999758 
S103 
 
C    -2.334470     4.408630     3.757603 
H    -0.750503     5.829007     4.100124 
H    -3.770585     2.918908     3.157190 
H    -2.821574     4.606533     4.707664 
C    -1.425703     2.843536    -1.421769 
C    -1.602746     1.465234    -1.570412 
C    -2.159701     3.740274    -2.206745 
C    -2.498445     0.987251    -2.520124 
H    -1.044688     0.764517    -0.959343 
C    -3.067875     3.252529    -3.136929 
H    -2.016510     4.811812    -2.105244 
C    -3.231175     1.877101    -3.297981 
H    -3.639829     3.945498    -3.746135 
H    -3.935674     1.499662    -4.032617 
H     1.922933     3.264448     1.553324 
H    -2.612067    -0.084998    -2.631836 
C     4.395826     0.239232    -0.612983 
C     4.325084     0.738685    -1.907251 
H     4.458865     0.059279    -2.738135 
S     2.026512     0.972250    -2.622057 
C     1.560978    -0.652622    -1.953119 
H     1.815967    -0.698977    -0.888969 
H     0.486581    -0.829269    -2.050980 
H     2.093273    -1.460360    -2.467630 
C     4.778236     2.153659    -2.158641 
H     4.409060     2.533697    -3.114849 
H     4.446709     2.828039    -1.361084 
H     5.876559     2.188426    -2.182412 
H     4.345188     0.957356     0.202399 
S104 
 
H    -1.708524    -2.736717     1.868994 
C    -0.645207    -4.194452     0.694265 
C     0.476026    -4.259236    -0.354288 
C    -0.146052    -4.746991     2.035504 
C    -1.826719    -5.050874     0.215769 
H     0.198013    -3.732388    -1.273075 
H     0.684573    -5.304749    -0.606805 
H    -0.976077    -4.866669     2.742513 
H     0.327575    -5.725314     1.896572 
H     0.591703    -4.076988     2.485002 
H    -1.523902    -6.103385     0.181216 
H    -2.686570    -4.974515     0.891517 
H    -2.155795    -4.769580    -0.790459 
C    -2.030225    -2.225356    -0.189442 
O    -1.589101    -1.880586    -1.282658 
N    -3.352476    -2.259913     0.093343 
H    -3.641653    -2.507899     1.029211 
C    -4.389776    -2.071081    -0.906370 
H    -3.901233    -2.238960    -1.871588 
C    -5.446874    -3.150045    -0.708613 
C    -6.477604    -2.984286     0.219011 
C    -5.351047    -4.353335    -1.409710 
C    -7.395995    -4.006444     0.442503 
H    -6.569316    -2.046105     0.760410 
C    -6.271714    -5.374806    -1.191384 
H    -4.551686    -4.488962    -2.134304 
C    -7.295275    -5.203939    -0.262058 
H    -8.193006    -3.865888     1.167147 
H    -6.188633    -6.304860    -1.746340 
S105 
 
H    -8.015649    -5.998775    -0.091275 
C    -4.977000    -0.665220    -0.922820 
C    -5.878661    -0.333037    -1.938452 
C    -4.641984     0.296226     0.027629 
C    -6.433249     0.939126    -2.007164 
H    -6.147024    -1.079670    -2.682257 
C    -5.207479     1.570440    -0.035462 
H    -3.920529     0.056633     0.805241 
C    -6.098437     1.897632    -1.051179 
H    -7.127575     1.184161    -2.806005 
H    -4.944565     2.314032     0.711532 
H    -6.530581     2.892852    -1.101349 
C     2.096057     1.513612     3.660070 
C     3.594654     1.363096     3.356574 
C     1.837611     2.889860     4.294343 
C     1.679639     0.433479     4.666794 
H     3.809102     0.423986     2.833981 
H     3.974986     2.189825     2.744248 
H     4.165313     1.366288     4.293087 
H     0.775907     3.021170     4.534224 
H     2.408082     2.987637     5.225526 
H     2.140717     3.716304     3.641202 
H     2.208700     0.578700     5.616281 
H     0.602655     0.468329     4.863615 
H     1.920764    -0.568717     4.298034 
C     4.233128    -3.356566     0.127027 
C     3.703261    -2.698960     1.247792 
C     3.258073    -3.427697     2.350191 
C     3.347487    -4.813619     2.297535 
S106 
 
C     3.850113    -5.459670     1.162710 
C     4.293232    -4.743691     0.051867 
C     4.209061    -1.090308    -0.135658 
H     3.007400    -5.404712     3.142822 
H     3.895461    -6.544344     1.138292 
H     4.674714    -5.251316    -0.822662 
N     4.569308    -2.314195    -0.770331 
N     3.682330    -1.333614     1.056641 
S     5.648001    -2.518305    -2.075242 
O     6.023202    -3.921130    -2.080375 
O     5.049549    -1.947742    -3.268510 
C     7.057307    -1.554038    -1.585122 
H     6.748886    -0.521778    -1.411348 
H     7.472529    -1.994086    -0.676680 
H     7.778550    -1.610164    -2.404295 
H     1.415401    -3.838910     0.021475 
H     2.850392    -2.914305     3.215950 
136 
mode B TS (E = -4263.566726 H) 
C    -3.258044    -2.556884     0.620128 
N    -1.905416    -2.054680     0.788823 
H    -1.167320    -2.502433     0.246811 
C    -1.519072    -1.189025     1.752088 
S    -2.627440    -0.394029     2.784845 
N    -0.187257    -0.987874     1.820879 
H     0.385115    -1.518193     1.158066 
C     0.510860    -0.416874     2.959182 
H    -0.256140    -0.242268     3.717885 
H     2.496952     0.746996     0.989758 
S107 
 
C     1.100210     0.976633     2.626850 
N     1.590894     1.177917     1.263098 
H     1.913606     1.208443     3.321413 
P     0.994389     2.281923     0.204486 
C     2.392185     2.824495    -0.798397 
C     3.611117     3.111229    -0.172446 
C     2.277383     2.928932    -2.187341 
C     4.705717     3.501048    -0.933179 
H     3.712324     3.006244     0.902815 
C     3.378989     3.316676    -2.943895 
H     1.341398     2.693302    -2.683475 
C     4.590444     3.599062    -2.318728 
H     5.652373     3.709005    -0.444722 
H     3.289192     3.389897    -4.023032 
H     5.450470     3.893517    -2.913151 
C     0.264526     3.677259     1.093564 
C     0.964487     4.876099     1.255619 
C    -1.005286     3.524898     1.667554 
C     0.398510     5.913487     1.990752 
H     1.941947     5.010432     0.803138 
C    -1.555380     4.559770     2.414322 
H    -1.560994     2.599343     1.539522 
C    -0.855959     5.754292     2.573149 
H     0.939178     6.847463     2.107297 
H    -2.531241     4.430966     2.872287 
H    -1.292127     6.564214     3.150026 
C    -0.288611     1.660785    -0.895492 
C    -0.351437     0.294612    -1.173505 
C    -1.176673     2.547887    -1.517708 
S108 
 
C    -1.319368    -0.188756    -2.046373 
H     0.348070    -0.393880    -0.711889 
C    -2.126630     2.059002    -2.405822 
H    -1.136867     3.612301    -1.305040 
C    -2.208323     0.691141    -2.656293 
H    -2.829087     2.742965    -2.871242 
H    -2.974496     0.304134    -3.320210 
H     0.318479     1.712962     2.817476 
H    -1.397536    -1.254071    -2.230346 
C     3.055385    -0.783821    -1.635767 
C     2.569397    -1.959322    -2.220435 
H     3.236563    -2.813955    -2.232643 
C     4.129095    -0.680388    -0.725777 
S     1.144345    -3.070182    -0.734006 
C     2.498169    -3.917796     0.137868 
H     3.359015    -3.249686     0.258890 
H     2.181225    -4.241696     1.133965 
H     2.827304    -4.801183    -0.419121 
C     1.677086    -1.853733    -3.429812 
H     1.150693    -2.788442    -3.634961 
H     0.941140    -1.051093    -3.320741 
H     2.303400    -1.611667    -4.299105 
H     2.393478     0.077060    -1.616461 
H    -3.786791    -2.286147     1.536475 
C    -3.318591    -4.105329     0.532432 
C    -2.529705    -4.689035    -0.647319 
C    -2.754968    -4.672665     1.843823 
C    -4.797731    -4.500217     0.404343 
H    -2.890707    -4.297999    -1.600638 
S109 
 
H    -1.456270    -4.475696    -0.575167 
H    -2.639791    -5.780303    -0.651354 
H    -3.292544    -4.281348     2.716247 
H    -2.846281    -5.764896     1.850790 
H    -1.693919    -4.427698     1.964074 
H    -4.901761    -5.590524     0.437709 
H    -5.398166    -4.081007     1.221200 
H    -5.224937    -4.156153    -0.543759 
C    -3.947387    -1.832925    -0.548942 
O    -3.730218    -2.086447    -1.730139 
N    -4.819797    -0.877183    -0.148018 
H    -4.953183    -0.733558     0.844427 
C    -5.628807    -0.103160    -1.072036 
H    -5.364441    -0.484950    -2.062271 
C    -7.103502    -0.408814    -0.821565 
C    -7.881075     0.372650     0.033762 
C    -7.672808    -1.540672    -1.410870 
C    -9.205576     0.029290     0.295370 
H    -7.454063     1.259546     0.493899 
C    -8.995973    -1.884168    -1.152319 
H    -7.070867    -2.156796    -2.074683 
C    -9.766858    -1.098489    -0.297341 
H    -9.800832     0.647967     0.961058 
H    -9.427100    -2.764464    -1.620684 
H   -10.801404    -1.362355    -0.097242 
C    -5.319026     1.385822    -1.038159 
C    -5.817629     2.191962    -2.066560 
C    -4.584558     1.978682    -0.013303 
C    -5.592065     3.563696    -2.069282 
S110 
 
H    -6.392759     1.737432    -2.870062 
C    -4.366985     3.356059    -0.009356 
H    -4.156488     1.367852     0.777227 
C    -4.866833     4.152893    -1.033581 
H    -5.984221     4.174106    -2.878003 
H    -3.795198     3.806053     0.796417 
H    -4.692242     5.225136    -1.028506 
C     1.513229    -1.436285     3.578548 
C     0.838944    -2.813324     3.676132 
C     2.793838    -1.540502     2.748245 
C     1.865709    -0.977006     5.001781 
H    -0.128726    -2.748358     4.188349 
H     0.668616    -3.258084     2.690121 
H     1.475997    -3.501257     4.243860 
H     3.385586    -0.622580     2.813319 
H     3.426210    -2.359893     3.109100 
H     2.581355    -1.723231     1.690667 
H     2.582650    -1.672800     5.452715 
H     2.326585     0.017080     5.019239 
H     0.975846    -0.948257     5.642408 
C     6.159261    -0.957318     0.268876 
C     5.367394    -0.014816     0.941282 
C     5.835847     0.592740     2.106339 
C     7.096246     0.232131     2.573055 
C     7.869056    -0.721222     1.901540 
C     7.406246    -1.341677     0.740837 
H     5.221613     1.317304     2.633862 
H     7.483271     0.689948     3.479104 
H     8.844852    -0.993700     2.292024 
S111 
 
H     8.001148    -2.085079     0.227240 
N     5.374747    -1.394688    -0.833156 
N     4.141946     0.127996     0.323367 
S     6.123259    -1.618246    -2.356619 
O     7.503420    -1.979919    -2.080659 
O     5.308181    -2.511146    -3.157531 
C     6.073124     0.016707    -3.062366 
H     5.027263     0.303640    -3.188455 
H     6.594342     0.700469    -2.389339 
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